These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 712614)

  • 1. Effects of pharmacological intervention on infarct size following induced myocardial infarction in rats.
    Barletta MA; Staab R; Lau Cam C; Lynch VD
    J Pharm Sci; 1978 Nov; 67(11):1643-5. PubMed ID: 712614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronidase-induced reductions in myocardial infarct size.
    Maclean D; Fishbein MC; Maroko PR; Braunwald E
    Science; 1976 Oct; 194(4261):199-200. PubMed ID: 959848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of infarct size following coronary occlusion.
    Braunwald E; Maroko PR; Libby P
    Circ Res; 1974 Sep; 35 Suppl 3():192-201. PubMed ID: 4606996
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion.
    Maroko PR; Braunwald E
    Circulation; 1976 Mar; 53(3 Suppl):I162-8. PubMed ID: 767015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efforts to limit the size of myocardial infarcts.
    Rude RE; Muller JE; Braunwald E
    Ann Intern Med; 1981 Dec; 95(6):736-61. PubMed ID: 6118084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early estimation of myocardial damage in conscious dogs and patients with evolving acute myocardial infarction.
    Shell WE; Lavelle JF; Covell JW; Sobel BE
    J Clin Invest; 1973 Oct; 52(10):2579-90. PubMed ID: 4729051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous hyaluronidase therapy for myocardial infarction in man: double-blind trial to assess infarct size limitation.
    Cairns JA; Holder DA; Tanser P; Missirlis E
    Circulation; 1982 Apr; 65(4):764-71. PubMed ID: 7060255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can infarct size be limited in patients with acute myocardial infarction?
    Muller JE; Braunwald E
    Cardiovasc Clin; 1983; 13(1):147-61. PubMed ID: 6129059
    [No Abstract]   [Full Text] [Related]  

  • 9. Limitation of myocardial infarct size. Present status.
    Yusuf S; Sleight P
    Drugs; 1983 May; 25(5):441-50. PubMed ID: 6134608
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum creatine phosphokinase activity following isoproterenol-induced myocardial infarction in male and female rats with and without arteriosclerosis.
    Wexler BC
    Am Heart J; 1970 Jan; 79(1):69-79. PubMed ID: 5410284
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of glucose-insulin-potassium on experimental myocardial infarction in the dog.
    Heng MK; Norris RM; Peter T; Nisbet HD; Singh BN
    Cardiovasc Res; 1978 Jul; 12(7):429-35. PubMed ID: 719656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of tissue creatine phosphokinase as a direct enzymatic method for evaluation of the area of necrosis in rats with isoproterenol-induced infarctions].
    Latte S; Genovese A; De Alfieri W; Polverino W; Cacciapuoti AA; Romano M; Chiariello M
    Minerva Cardioangiol; 1981 Nov; 29(11):599-602. PubMed ID: 7329563
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of a highly purified hyaluronidase preparation on experimental myocardial infarction in the rat.
    Nilsson JE; Sjögren C; Säwe U
    Acta Med Scand; 1984; 216(2):209-13. PubMed ID: 6496178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity.
    Shell WE; Kjekshus JK; Sobel BE
    J Clin Invest; 1971 Dec; 50(12):2614-25. PubMed ID: 5129313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion.
    Maroko PR; Libby P; Sobel BE; Bloor CM; Sybers HD; Shell WE; Covell JW; Braunwald E
    Circulation; 1972 Jun; 45(6):1160-75. PubMed ID: 5032816
    [No Abstract]   [Full Text] [Related]  

  • 16. A method for demonstrating the efficacy of interventions designed to limit infarct size following coronary occlusion: beneficial effect of hyaluronidase.
    Riberio LG; Hillis LD; Louie EK; Davis MA; Maroko PR; Braunwald E
    Cardiovasc Res; 1978 Jun; 12(6):334-40. PubMed ID: 698985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hyaluronidase and hydrocortisone on myocardial necrosis after coronary occlusion.
    Braunwald E; Maroko PR
    Am J Cardiol; 1976 Mar; 37(4):550-6. PubMed ID: 1258792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of mannitol, hyaluronidase and glucose-insulin-potassium in the treatment of acute myocardial infarction (author's transl)].
    Hirzel HO
    Herz; 1981 Apr; 6(2):98-106. PubMed ID: 6785178
    [No Abstract]   [Full Text] [Related]  

  • 19. [Electron-microscopic study of changes in the myocyte ultrastructure under the effect of hyaluronidase in experimental myocardial infarct].
    Afonskaia NI; Sharov VG; Nikolaeva LF
    Kardiologiia; 1977 Aug; 17(8):114-8. PubMed ID: 926553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Model of myocardial infarct in rats for research on anti-infarct pharmacological preparations].
    Somova L; Machuganska A; Dashev G; Zlatareva N; Vasileva M
    Eksp Med Morfol; 1987; 26(1):50-5. PubMed ID: 3595498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.